Stock Markets March 12, 2026

Volution H1: Revenue Jumps 22% as EPS and Guidance Top Estimates

Strong M&A contribution and steady organic growth underpin margin resilience and a raised end-of-year EPS outlook

By Nina Shah FAN
Volution H1: Revenue Jumps 22% as EPS and Guidance Top Estimates
FAN

Summary: Volution Group reported first-half fiscal 2026 results that beat analyst expectations, driven by a 22% rise in revenue to 3,229 million and a 4% outperformance on earnings per share. Organic sales grew 4.2% with pricing adding 0.6 percentage points, while acquisitions and foreign exchange provided substantial uplift. Management raised its adjusted earnings-per-share placement to the top end of market forecasts for fiscal 2026, representing an incremental upgrade of about 2%.

Key Points

  • Volution reported H1 revenue of 229 million, up 22% year-over-year, with organic growth of 4.2% and pricing adding 0.6 percentage points.
  • EBITA was 51.6 million (up 21%) and EPS rose 19% to 18.2p; the board raised its expected adjusted EPS to the top end of market forecasts, a roughly 2% upgrade.
  • Balance sheet and cash: dividend increased 18%, cash conversion was 98%, net debt 186 million and leverage 1.3x. Implications span ventilation manufacturing, residential and commercial construction supply chains, and regional building markets.

Results overview

Volution Group plc delivered first-half fiscal 2026 results that exceeded market forecasts, with adjusted earnings per share coming in 4% ahead of consensus. The ventilation products manufacturer recorded revenue of 229 million for the period, a 22% increase year-on-year. Organic revenue expansion was 4.2%, of which pricing contributed 0.6 percentage points. Mergers and acquisitions accounted for a 16.4% uplift and foreign exchange provided a 1.1% tailwind to top-line growth.

Earnings before interest, tax and amortization (EBITA) rose to 51.6 million, up 21% from the prior year and 2% ahead of consensus estimates. Reported EBITA margin was 22.6%, a slight decline of 10 basis points compared with the year-earlier period. Reported earnings per share increased 19% to 18.2p.

Capital allocation and balance sheet

The company increased its interim dividend by 18% and reported strong cash conversion of 98%. Net debt at period end was 186 million, with leverage at 1.3 times, reflecting the balance between acquisition activity and cash generation.

Regional performance

All three geographic divisions reported organic revenue growth that fell within Volution's stated framework range of 3% to 5%.

  • United Kingdom: Organic revenue grew 3.8%. Residential sales rose 4.2%, exports jumped 20.3% and OEM business expanded 7.6%. Commercial revenue declined 7.3%. UK margins improved 60 basis points to 26.3%.
  • Europe: Organic revenue increased 5.3%, with the Nordics up 4.1% and Central Europe up 6.0%. The ClimaRad business in the Netherlands was highlighted as a particularly strong performer, while Germany has stabilised. Belgium and France were cited as remaining challenging. European margins expanded 120 basis points to 25.3%.
  • Australasia: Organic revenue growth was 3.3%, driven by residential growth of 5.2% and commercial growth of 1.9%. The acquired Fantech business contributed 227% to divisional growth. In New Zealand, residential gains were supported by the 2023 acquisition of DVS. Margins in the region declined 100 basis points, with the company attributing the contraction to the impact of the Fantech acquisition.

Outlook

The board now expects adjusted earnings per share for fiscal 2026 to be at the top end of the range of market forecasts, an upgrade of approximately 2% from prior guidance. Management's commentary signals confidence in the company's ability to convert revenue gains into sustained earnings, while continuing to integrate recent acquisitions.


Analytical note

The H1 results show a mix of organic momentum, pricing contribution and substantial M&A-driven expansion. Margin trends vary by region - with UK and Europe delivering margin expansion, while Australasia experienced margin dilution linked to acquisition accounting and integration costs. Net leverage remains moderate at 1.3 times and near-full cash conversion supports the dividend increase and the board's upgraded EPS placement for the year.

Risks

  • Regional performance disparities - Belgium and France were described as challenging, which could weigh on European recovery in certain markets.
  • Commercial demand softness in the UK - commercial revenue fell 7.3%, presenting a downside risk to UK divisional momentum if the trend persists.
  • Margin pressure in Australasia attributable to acquisition integration - margins declined 100 basis points following the Fantech acquisition, highlighting execution and integration risk for M&A activity.

More from Stock Markets

Pharming Posts Q4 Revenue of $106.5m, Maintains 2026 Financial Targets Mar 12, 2026 Lightwave Logic Shares Spike After Development Pact With Tower Semiconductor Mar 12, 2026 Lilly warns of unknown impurity in compounded versions of its weight-loss drug Mar 12, 2026 Taiwan’s Major Parties Clear Way for Government to Sign U.S. Arms Agreements Ahead of Deadlines Mar 12, 2026 UK markets slip as oil tops $100; pound eases below $1.34 amid Middle East tensions Mar 12, 2026